pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-552 |
Genomic Coordinates | chr1: 34669599 - 34669694 |
Synonyms | MIRN552, hsa-mir-552, MIR552 |
Description | Homo sapiens miR-552 stem-loop |
Comment | None |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-552-5p | ||||||||||||||||||||||||
Sequence | 25| GUUUAACCUUUUGCCUGUUGG |45 | ||||||||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||||||||
Experiments | Illumina | ||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | MLLT10 | ||||||||||||||||||||
Synonyms | AF10 | ||||||||||||||||||||
Description | MLLT10, histone lysine methyltransferase DOT1L cofactor | ||||||||||||||||||||
Transcript | NM_004641 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on MLLT10 | |||||||||||||||||||||
3'UTR of MLLT10 (miRNA target sites are highlighted) |
>MLLT10|NM_004641|3'UTR 1 CAAGACTTAGTGATAAAACTGGGCCTGTAGCTCAAGAGAAAAGTTGACACCTGAGAAACATCTAGAAATTGCCTATCCTG 81 CTGTTCTAGCACTTCATCTGGCTGCCTTTGCAGTCCTTTTACTACAGCTATGAAGAAACGCAACAAGAAACTCAATGCAC 161 AACAAAGGATTAATTGCTGCAAGGACATTCTTGTAAGGCTTTGATTAGTTTTCTTGTTGCTTTGTTGCACTGAAATGGAA 241 TTCCCATGCCCCTACCCCTTACCCCAGTTTTTTGAACATGGAAAGAAAATTTAATAACTTTTTAAAGTGACATAATTTAC 321 ATGCAATATGTTTATCAACTCAAGAATTTAATATAGTTGGTACACAACTAGTTTTGTTTATAAATTGGAGATGCAAATAG 401 CAAAACTAAATACTTGCTCCATTTACAAACTACTTGATTTTATTGTACAAGTTGAAATATGCTCTTTTGTTTGGGTTACA 481 GTATGCTTGCTCTAAGTCAAATTCCAAGGAACTAATTTCTTCTCCTGGAGTTGCATTGATTCAGTATTACAAATATATAG 561 CACATCACCTGGGACTTGGCAATCTTTGTTAAAAAAAAATTTCCTTTCTAATGGGATTTGGCCAATTTTGGTAATGAAGT 641 TAGGATGGTAATGTCTGCATCTGCTAAAGGTAATTTTCTTTTGAGAATTGCTTTCTTTAGTGTTAAGACCTACTCATATT 721 TTGAAGAAATCTTGAGTTAAGTGAGTTCTGAGGCTGCTGGGGGAACCAGATCAATTCAAAGCTAAATACTTCTTTCAGAA 801 AGGGGCCACTGTGGAAAGTGCTGGTGGGGTTTGCCCTTGATCAAGTGCCTCCATTGTGCTGCAAGGGCTGTAGACAGCAG 881 GGTGGGACAGTCAGTCCTCCGAGCAGCAGGAATCATCCCGTCACCTGCAGCCTTCCCATGCTTCCGCCTTTATTCAGAAC 961 TTTCTGTGCCACTGTAGATAGCTCAGGCAAAACTATTACCTGGGTATTTATCCACTAATGAGTCACAAGAAAAGGAGTGG 1041 ATTTGGTAAGAATAGAGATTTGTTTTATTTAAACCACTTCCCATTACTGACCATTAAAAGCTCACCACTAGAGTTCCTGA 1121 AACAGGTGAAACCTGTATGACAGCCCTTCCACTTTGGGGAGCCACGCTTTTGATGTGACAGTACCGCAGAGTGATTCCCC 1201 CACTGAGGATGTCATCATCAAACTCTTCTTTGGTGTGTGAATTATTAGTGGAAAAGACCCAGCTGTAATTAGACCTCCAC 1281 TGTGTACTTAGCTGGAAGAACATGTTAATTCTGCAATATGTTTCTTGGTTAAACATTGCACAGTTCTTACCTCATTTCTG 1361 TAAATAAAGTTTTGTGAATCTGTTTTGTATTGTGACAAATTCATAAGATAACATTGATATTTTGATTTGTAATATTTCTA 1441 ATTGGTAGATTTAATTGAAAAGTAAAATTAATTTATTTTTATATGTTCAGGGGAATTTTAAAGTCAAATCTTTTGTAGAT 1521 AATTTAAAAAATCAGTGTGGTTTATTTTACTTATTTAACCCACTGGTTGTTATTCTGTAACAGTTTGTATAAATGGTAAA 1601 TTTTGAATGTGTTGTTATTTTACCTAGATGTAAAATTCCACATGTATTAAAATGTACAAAATGTTTTGTTAATAAAATTT 1681 AATAATGTTTATAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | TZM-bl |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | Prostate Tissue | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in SRX1760597. RNA binding protein: AGO2. Condition:AGO-CLIP-LNCaP_C
... - Hamilton MP; Rajapakshe KI; Bader DA; Cerne et al., 2016, Neoplasia (New York, N.Y.). |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Hamilton MP; Rajapakshe KI; Bader DA; Cerne et al. - Neoplasia (New York, N.Y.), 2016
MicroRNA (miRNA) deregulation in prostate cancer (PCa) contributes to PCa initiation and metastatic progression. To comprehensively define the cancer-associated changes in miRNA targeting and function in commonly studied models of PCa, we performed photoactivatable ribonucleoside-enhanced cross-linking immunoprecipitation of the Argonaute protein in a panel of PCa cell lines modeling different stages of PCa progression. Using this comprehensive catalogue of miRNA targets, we analyzed miRNA targeting on known drivers of PCa and examined tissue-specific and stage-specific pathway targeting by miRNAs. We found that androgen receptor is the most frequently targeted PCa oncogene and that miR-148a targets the largest number of known PCa drivers. Globally, tissue-specific and stage-specific changes in miRNA targeting are driven by homeostatic response to active oncogenic pathways. Our findings indicate that, even in advanced PCa, the miRNA pool adapts to regulate continuing alterations in the cancer genome to balance oncogenic molecular changes. These findings are important because they are the first to globally characterize miRNA changes in PCa and demonstrate how the miRNA target spectrum responds to staged tumorigenesis.
LinkOut: [PMID: 27292025]
|
CLIP-seq Support 1 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000377072.3 | 3UTR | UUAAACAUUGCACAGUUCUUACCUCAUUUCUGUAAAUAAAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
118 hsa-miR-552-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT060509 | PPP6R3 | protein phosphatase 6 regulatory subunit 3 | 2 | 2 | ||||||||
MIRT061011 | C1ORF21 | chromosome 1 open reading frame 21 | 2 | 6 | ||||||||
MIRT090823 | MBNL1 | muscleblind like splicing regulator 1 | 2 | 4 | ||||||||
MIRT126569 | MASTL | microtubule associated serine/threonine kinase like | 2 | 2 | ||||||||
MIRT147688 | CBX4 | chromobox 4 | 2 | 4 | ||||||||
MIRT191746 | ELMSAN1 | ELM2 and Myb/SANT domain containing 1 | 2 | 4 | ||||||||
MIRT202397 | GPCPD1 | glycerophosphocholine phosphodiesterase 1 | 2 | 2 | ||||||||
MIRT231334 | XRRA1 | X-ray radiation resistance associated 1 | 2 | 8 | ||||||||
MIRT241355 | SLC16A1 | solute carrier family 16 member 1 | 2 | 2 | ||||||||
MIRT280627 | BCL11B | B-cell CLL/lymphoma 11B | 2 | 2 | ||||||||
MIRT287408 | GPATCH8 | G-patch domain containing 8 | 2 | 2 | ||||||||
MIRT314310 | FCHO2 | FCH domain only 2 | 2 | 2 | ||||||||
MIRT321751 | ANKRD46 | ankyrin repeat domain 46 | 2 | 2 | ||||||||
MIRT329335 | ETF1 | eukaryotic translation termination factor 1 | 2 | 2 | ||||||||
MIRT346611 | PMAIP1 | phorbol-12-myristate-13-acetate-induced protein 1 | 2 | 6 | ||||||||
MIRT349189 | ZNF557 | zinc finger protein 557 | 2 | 2 | ||||||||
MIRT357416 | HNRNPA0 | heterogeneous nuclear ribonucleoprotein A0 | 2 | 2 | ||||||||
MIRT359670 | NUS1 | NUS1 dehydrodolichyl diphosphate synthase subunit | 2 | 2 | ||||||||
MIRT442751 | PLAG1 | PLAG1 zinc finger | 2 | 6 | ||||||||
MIRT446639 | SPTY2D1 | SPT2 chromatin protein domain containing 1 | 2 | 2 | ||||||||
MIRT450820 | KCNB1 | potassium voltage-gated channel subfamily B member 1 | 2 | 2 | ||||||||
MIRT452304 | EIF5AL1 | eukaryotic translation initiation factor 5A-like 1 | 2 | 2 | ||||||||
MIRT468814 | RSRC2 | arginine and serine rich coiled-coil 2 | 2 | 6 | ||||||||
MIRT471878 | NUFIP2 | NUFIP2, FMR1 interacting protein 2 | 2 | 6 | ||||||||
MIRT472681 | MYCBP | MYC binding protein | 2 | 4 | ||||||||
MIRT473123 | MLLT10 | MLLT10, histone lysine methyltransferase DOT1L cofactor | 2 | 2 | ||||||||
MIRT477434 | EML4 | echinoderm microtubule associated protein like 4 | 2 | 4 | ||||||||
MIRT501254 | SECISBP2L | SECIS binding protein 2 like | 2 | 2 | ||||||||
MIRT501586 | PLCG1 | phospholipase C gamma 1 | 2 | 2 | ||||||||
MIRT503371 | SCAMP1 | secretory carrier membrane protein 1 | 2 | 2 | ||||||||
MIRT504358 | ARID1B | AT-rich interaction domain 1B | 2 | 6 | ||||||||
MIRT504421 | SHC4 | SHC adaptor protein 4 | 2 | 6 | ||||||||
MIRT505497 | SRSF1 | serine and arginine rich splicing factor 1 | 2 | 4 | ||||||||
MIRT505792 | RSBN1 | round spermatid basic protein 1 | 2 | 8 | ||||||||
MIRT506471 | NAA25 | N(alpha)-acetyltransferase 25, NatB auxiliary subunit | 2 | 4 | ||||||||
MIRT507372 | EPS8 | epidermal growth factor receptor pathway substrate 8 | 2 | 2 | ||||||||
MIRT510850 | RAN | RAN, member RAS oncogene family | 2 | 8 | ||||||||
MIRT510986 | PER1 | period circadian clock 1 | 2 | 4 | ||||||||
MIRT512987 | SEZ6L | seizure related 6 homolog like | 2 | 4 | ||||||||
MIRT514937 | GPR141 | G protein-coupled receptor 141 | 2 | 2 | ||||||||
MIRT522131 | NRBF2 | nuclear receptor binding factor 2 | 2 | 6 | ||||||||
MIRT524300 | CTC1 | CST telomere replication complex component 1 | 2 | 8 | ||||||||
MIRT526363 | LSAMP | limbic system-associated membrane protein | 2 | 2 | ||||||||
MIRT526441 | RBM48 | RNA binding motif protein 48 | 2 | 2 | ||||||||
MIRT526534 | MDM2 | MDM2 proto-oncogene | 2 | 4 | ||||||||
MIRT528065 | HES2 | hes family bHLH transcription factor 2 | 2 | 2 | ||||||||
MIRT531043 | TIPARP | TCDD inducible poly(ADP-ribose) polymerase | 2 | 2 | ||||||||
MIRT532313 | FKBP9 | FK506 binding protein 9 | 2 | 4 | ||||||||
MIRT533196 | WASF3 | WAS protein family member 3 | 2 | 4 | ||||||||
MIRT535701 | NAV1 | neuron navigator 1 | 2 | 5 | ||||||||
MIRT536791 | HNRNPA2B1 | heterogeneous nuclear ribonucleoprotein A2/B1 | 2 | 2 | ||||||||
MIRT537228 | GALNT7 | polypeptide N-acetylgalactosaminyltransferase 7 | 2 | 6 | ||||||||
MIRT538247 | CUX2 | cut like homeobox 2 | 2 | 2 | ||||||||
MIRT538476 | CLOCK | clock circadian regulator | 2 | 2 | ||||||||
MIRT538798 | C2CD5 | C2 calcium dependent domain containing 5 | 2 | 2 | ||||||||
MIRT539031 | ATXN7L1 | ataxin 7 like 1 | 2 | 2 | ||||||||
MIRT542043 | SLC25A46 | solute carrier family 25 member 46 | 2 | 2 | ||||||||
MIRT543093 | TNFRSF11A | TNF receptor superfamily member 11a | 2 | 2 | ||||||||
MIRT543545 | INTS2 | integrator complex subunit 2 | 2 | 2 | ||||||||
MIRT554332 | SH3GLB1 | SH3 domain containing GRB2 like, endophilin B1 | 2 | 4 | ||||||||
MIRT556070 | MRFAP1 | Morf4 family associated protein 1 | 2 | 2 | ||||||||
MIRT558125 | ENPP4 | ectonucleotide pyrophosphatase/phosphodiesterase 4 (putative) | 2 | 2 | ||||||||
MIRT559132 | BTG3 | BTG anti-proliferation factor 3 | 2 | 4 | ||||||||
MIRT559423 | ASF1A | anti-silencing function 1A histone chaperone | 2 | 2 | ||||||||
MIRT560026 | ZNF780A | zinc finger protein 780A | 2 | 2 | ||||||||
MIRT566128 | RACGAP1 | Rac GTPase activating protein 1 | 2 | 2 | ||||||||
MIRT566441 | PHF13 | PHD finger protein 13 | 2 | 2 | ||||||||
MIRT568541 | AKT3 | AKT serine/threonine kinase 3 | 2 | 2 | ||||||||
MIRT568626 | ACVR2A | activin A receptor type 2A | 2 | 2 | ||||||||
MIRT576599 | Nav1 | neuron navigator 1 | 2 | 4 | ||||||||
MIRT609438 | USP27X | ubiquitin specific peptidase 27, X-linked | 2 | 2 | ||||||||
MIRT611441 | NRIP3 | nuclear receptor interacting protein 3 | 2 | 2 | ||||||||
MIRT613007 | GABRB1 | gamma-aminobutyric acid type A receptor beta1 subunit | 2 | 2 | ||||||||
MIRT614149 | CEP97 | centrosomal protein 97 | 2 | 2 | ||||||||
MIRT614580 | LHX1 | LIM homeobox 1 | 2 | 2 | ||||||||
MIRT615631 | ATF6 | activating transcription factor 6 | 2 | 4 | ||||||||
MIRT616115 | NDUFS1 | NADH:ubiquinone oxidoreductase core subunit S1 | 2 | 2 | ||||||||
MIRT620351 | WDR75 | WD repeat domain 75 | 2 | 2 | ||||||||
MIRT621733 | TNPO2 | transportin 2 | 2 | 2 | ||||||||
MIRT623718 | HACE1 | HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1 | 2 | 2 | ||||||||
MIRT626107 | MYLIP | myosin regulatory light chain interacting protein | 2 | 2 | ||||||||
MIRT630779 | CRLS1 | cardiolipin synthase 1 | 2 | 2 | ||||||||
MIRT632585 | PLCL1 | phospholipase C like 1 (inactive) | 2 | 2 | ||||||||
MIRT635161 | HOXD12 | homeobox D12 | 2 | 2 | ||||||||
MIRT635878 | SIX3 | SIX homeobox 3 | 2 | 2 | ||||||||
MIRT636941 | LIMS3 | LIM zinc finger domain containing 3 | 2 | 2 | ||||||||
MIRT637007 | LIMS3L | LIM zinc finger domain containing 4 | 2 | 2 | ||||||||
MIRT639202 | LRRC9 | leucine rich repeat containing 9 | 2 | 4 | ||||||||
MIRT639388 | PKHD1 | PKHD1, fibrocystin/polyductin | 2 | 2 | ||||||||
MIRT639543 | SMCR7L | mitochondrial elongation factor 1 | 1 | 1 | ||||||||
MIRT642071 | FUT11 | fucosyltransferase 11 | 2 | 2 | ||||||||
MIRT642567 | GDPGP1 | GDP-D-glucose phosphorylase 1 | 2 | 2 | ||||||||
MIRT643035 | SNX24 | sorting nexin 24 | 2 | 2 | ||||||||
MIRT648372 | SMPD1 | sphingomyelin phosphodiesterase 1 | 2 | 2 | ||||||||
MIRT648529 | KIAA1143 | KIAA1143 | 2 | 2 | ||||||||
MIRT652184 | TRIM44 | tripartite motif containing 44 | 2 | 2 | ||||||||
MIRT652945 | SYNC | syncoilin, intermediate filament protein | 2 | 2 | ||||||||
MIRT657012 | KCNK5 | potassium two pore domain channel subfamily K member 5 | 2 | 2 | ||||||||
MIRT658993 | DIP2C | disco interacting protein 2 homolog C | 2 | 2 | ||||||||
MIRT659629 | CDKN2AIP | CDKN2A interacting protein | 2 | 2 | ||||||||
MIRT659769 | CCBE1 | collagen and calcium binding EGF domains 1 | 2 | 2 | ||||||||
MIRT660527 | ARIH1 | ariadne RBR E3 ubiquitin protein ligase 1 | 2 | 2 | ||||||||
MIRT668526 | ERP44 | endoplasmic reticulum protein 44 | 2 | 2 | ||||||||
MIRT687184 | PRKAR1A | protein kinase cAMP-dependent type I regulatory subunit alpha | 2 | 2 | ||||||||
MIRT696280 | IER3IP1 | immediate early response 3 interacting protein 1 | 2 | 2 | ||||||||
MIRT697673 | WASL | Wiskott-Aldrich syndrome like | 2 | 2 | ||||||||
MIRT697716 | VKORC1L1 | vitamin K epoxide reductase complex subunit 1 like 1 | 2 | 2 | ||||||||
MIRT699719 | SESTD1 | SEC14 and spectrin domain containing 1 | 2 | 2 | ||||||||
MIRT701220 | OGDH | oxoglutarate dehydrogenase | 2 | 2 | ||||||||
MIRT701436 | NFYA | nuclear transcription factor Y subunit alpha | 2 | 2 | ||||||||
MIRT701554 | NANOS1 | nanos C2HC-type zinc finger 1 | 2 | 2 | ||||||||
MIRT707559 | CLVS2 | clavesin 2 | 2 | 2 | ||||||||
MIRT707925 | PPP1R3D | protein phosphatase 1 regulatory subunit 3D | 2 | 2 | ||||||||
MIRT711148 | NAA15 | N(alpha)-acetyltransferase 15, NatA auxiliary subunit | 2 | 2 | ||||||||
MIRT719256 | CD44 | CD44 molecule (Indian blood group) | 2 | 2 | ||||||||
MIRT719810 | TXNDC17 | thioredoxin domain containing 17 | 2 | 2 | ||||||||
MIRT722650 | SIGLEC14 | sialic acid binding Ig like lectin 14 | 2 | 2 | ||||||||
MIRT723901 | PEX11A | peroxisomal biogenesis factor 11 alpha | 2 | 2 |
miRNA-Drug Associations | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|